Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Research & Development: 2016-2024

Historic Research & Development for Solid Biosciences (SLDB) over the last 9 years, with Dec 2024 value amounting to $96.4 million.

  • Solid Biosciences' Research & Development rose 99.12% to $30.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $96.4 million, marking a year-over-year increase of 25.95%. This contributed to the annual value of $96.4 million for FY2024, which is 25.95% up from last year.
  • Solid Biosciences' Research & Development amounted to $96.4 million in FY2024, which was up 25.95% from $76.6 million recorded in FY2023.
  • Solid Biosciences' 5-year Research & Development high stood at $96.4 million for FY2024, and its period low was $58.7 million during FY2021.
  • Over the past 3 years, Solid Biosciences' median Research & Development value was $78.4 million (recorded in 2022), while the average stood at $83.8 million.
  • As far as peak fluctuations go, Solid Biosciences' Research & Development tumbled by 31.51% in 2020, and later spiked by 33.51% in 2022.
  • Over the past 5 years, Solid Biosciences' Research & Development (Yearly) stood at $64.9 million in 2020, then decreased by 9.47% to $58.7 million in 2021, then skyrocketed by 33.51% to $78.4 million in 2022, then fell by 2.37% to $76.6 million in 2023, then grew by 25.95% to $96.4 million in 2024.